Review o Eack Arhcle

|. Drummne et al. - Methods fo the eca

RConoic

cualuakn Heath Cae Programmas

.Scope and Conthbutns
- Arovi deo un ex tensve Duerview y al m4or
evaluatn techniqhes: Cost - elechve anahss CCG)
Cout utlt analysis CcuA), st- benefit analysgC
qnd Cost - mn,mi 2atn ana lysis CcmnA)
- blyers Prat caf gu dane n Shnchnng Studio,
outcmes (e9
ncremtal Cost-eJecfvenem rocfieo CIcERS
- frequenty teference in acadenic Gnd palit
na king cntex ts for ib m thodo logra nigor E
Limitatii
- Beng a Cimprehenve lesource, t may be tu
letuled for neaders new fo tie feld.
Some Sect not
map Goer the venp laotest
metrhocologitol obuanCement, G the frer d
Gonhhonoly 2uelng

2. Gold et al. - aH - /echvensn in Hea ltk and

me dicne(1996)
Scope Cn Con tbutno
- Senues a a benchmar k fu Cast- hechvens
me thod o lo9y:
- stablk3hes Sftn dark praChco bow Coots and
Gutun Should be eoowre d Gnd CmPaned
Reuiew a tacd Arhcle
Drummnd et al. - Meods fx the cconomnic
cualuahun Heath Cane Prog rammes
. Scope and Conhbutns
- Provi des un extemive
<xtenoive Duerui ew al myor
eualuatn techniques: ast - elechve anayss (Ca), E
Cost utlty analsis cuA), ast- bennst anlysg(G
and Cost - mni Mi 2atn analysis CcmA)
- bles Prat cal gudane on Shmchnng Stuie,
Muaunng outcumes (e9 QALY), nd Calalab
ngenotal Cost-ajecfvene raheo C1CERs)
- frquety tejuenet
na king contex ts or ib ne Hhodo logral rig or
Limitatnoi
-Beng G Comprehensve tesou Ce, t may be tou
lefuled for neaders new to the feld.
- Some Sect map naf Cover the vep laotnt
ethoclologrtof odja n Cemenft, n the tied
Gonhhonshy kuolvmg

Medicne( 1996)
Sco pe anc Contbud o
-Seres Gn
me thodo logy
benchmor k sor Cast- echvews
- stobl3kes Stndard haches h bow Caot
Gwtcn and
Should be
 (5
SHACHAH UNITED

Iahlwenca d mamy Gn) mtemanal

h atnal ano
YdeLrup amo temaw a Cove tejerence dospk
heng pu bl she d h 1996.
Latetms
Sime umph and thneholds CIike the
G/fen-cied 50, DD - per- QALY ben chmost) ae
debated tada
.The ne thudolosies hane bcen refîned Sne ib
Dubicehn, So newer arhes bu l on dnd upoate
re (oMnen datn

2. Weinstein et al - bundahuno o Cost-ejachum

Arnahes.S for Hea He on
Scoe oml Conbmbutn

hor Cmluchng CA
betwee
by dis Cursing boTh cnalgtical fechniquis Gand Yealal–
h re
wrrld chkallengeo
oCuphcwi2es the m Dortane tano Darene
metcls and fh nacd for Canl hub analyseo
himitatio
Wule koundohima, It mop hot addrem moye reo
n nov ohvn m de isnm analyhc modelivng or the
ewer G data
Kingdom relevance and
expansion
through love and the Gosp
el
 Sone Brdchcd exanples migkt be doted telahve to
Gunent healtt economic Chalen ges
3YUHAHDAH2
4.
t. Neumahn et al - Uptatng Cost-<ķfckvenep
umsws Aesilence o te sso, cUD -prQA
tnes kot& (2014)
•S Cope and Conto butoo
- Revisb and cnhCally evcluates te kas fon Cal Cast
<flechveneo theshol d, Spar kmg dscmon ita
selevance în Curent evaluaton.
thghlights toe mlorton e of senoihuy analysa
in teohno the ob ustne o Cncluoiono drawn E

nudes Contest on how economz tro kelds

healh ca re.

intatuns
focwoes rinarte on te tre hold oebcte, so
So tmey e
not over fhe hui spectu m zwaluahn fools.
– (ft emf laois n QALYs wight nof Sut evenp
Dhavna CoeConUic Rvaluty that includy non-QAL
Outao

5.Gamson et al. - budgat

lmpact AnaysT -
frncples f aoo rache (a02)
Scope and Cont butno
Loutlnas a stnctuno approedh to Derfomng
budhet p a ct anaysis (BrA), on hcreGoing hy
 SHACHAHUNITED
- Provi des detsed audane on he practa
the Contet
decism vma Kng
-Gpkaniteo franapanenty ord Cowosten.Makaig
makers

Lintatm
- The hocuo on biA meano t does not oe

- As with mamy pa methodoloqıral repoh

ea- wo|e applicahun map requie adapthun
to Specs hea lk care Sy Stem Lontext
:Decison Tres stuchare
1.1 Chloroquine frst Arm AD

Cnti5) Pruba bilky OCne 35

Take choroguwhe
G5% taal cQ

Take Ac C450)
q8l% Cure29- Deutth

Cure
Tahe SP Czo)
324% fail Se

Take Ac C 450

Chlbrequine-frst Rate
Cure wth Chloroqwe 3s1
Fl chlor oquine ' G516
bal, Gue wth
Y81 o E59% = o65x 0-96 = O.637 (63Tb
 SHACHAH UNITED

a deosim hree appsach fo Canpare

huo treatnent shratugies The

slch nhad therapy ( ar SP) nure

Cost
ejechve ohen olawed te
sals, ci alss the ot
kit feetment
dects to Soiely

- Cost of Cklerequne Cca) per patheat : tl5

Pr ba bly o Cure with CaiA 357.

Probaby o, Cure witk AcT Cajter Q feils)i ?s

Pro babl daafk i ACT beals i2 fhese
- Cast o deat to Socieky: H 25 oU

8 Opkun 2: SP frst
-Cost o SP 2er patient :*120
LPro babil y of Cure wit SP: 68%
aesP_hak
SP 32%), pecties takes ACT at 450
(S conme Šucces rate ao above 987)
Probabily deatk if AT 2% feose wo
tuk AG
Kingdom relevance and expansion
through love and the Gospel
 SHACHAH UNITED

of Hose he hal att 2 657,z 0.65x

o02O.OrCI:39J)
Tofaf Cue Rate 357.(Ca)t 63-7% CAT)
98:71%
-To fal Deate Rate : 37o

SP- fos late

Cure SP6s %
wth
3Fal SP 32%
of fhese lig hal, Cure with ACT:
787. 32, > 0 32 x o.98 = .3136
31-36e
of those toho hal, Death :: 2%% 4L 32, =
O.32 X0.O2= 0. 00b4
O.64
Total Cure Rate = 68o CsP) t 31.36,CA)
E99. 367o
Tofal Death Rete = O. 64%

Calculekne x pecte d Costs

Ne mcate both treatned Cstb gnd te Cast of
decth C250, 0UU per death) h the cnahys
Chloroqune - fost Dat
JBo e Cort CCQ):5Cfr even
Bane
2 ACT Cast Cfr Ca nalree Patiet )
nae & ACT af )65% 6f patierth
450 eeCyingd
om relevance a nd expansion
through love and th
e Gospel
 Ex pected ACT Cast er pot'et- 065 x 450
- 292- 5o
4. Total Teatnet Cost Cca t ACT)DA2
(5 + a92.50 = N 307 50 per pehet

4- Cost
-Probabiuty of becth = 3% = o.0|3
eoth Cost Der Date = 0.I3 x 250,csD
=A3250

5 Gal Dxpecto d (ost (Chlacquine rfirst)

3075o( treatmet ) + 3.25o (cdaeth) =
3559.50 jer patient

G. Overoll Cure ate 98-71%. 09S?

Cost - ehectvenes (cE) Rat =

(ofel Cx pecte) Cost 255. 5o
Cure Rote
N3603.44

SP-frs pate
2- Ar Cost (for SP halure) 32%. oh pahiens nad
AcT at 450 each
TKpecte d AcT Cost per Datieid = 0.32 x 450
3 Total Trectvend Cost (SP t Ac) = I44
26 4 Per phest
 SHACHAH UNITED
4. Cast o Deat :
Probab.liy dect 0.Gy = 0-0064f
Death Cosf pe Dahet = O-COby x 250a

5- (ofal xpected Cast CSP- frst)

264 CTreatnedt) t kvD C beat) = /864 per ahed
C Overal Cure Rate : 29-36%= 0.93 6

Eachveners (Ca) Katro

Cost
Total x Retek Cast
Cuwe Rcde Cure

4.h. Com panson and Policy Recomenbahen

Chloroquin t AcT Appro och
- Cure Rate : q8-7%

ACT Approc chi

Rate 9.36o
Cost er Cuve m,ST6. 21
hum a a
CE standpant , SPt AcT donihates
hao a bota Aig her Cure rode a nd
an
(oNer Cast per Succemjl trectmet th
Chlor oqune t ACr
the
ven ese resultoSP shold be
ine reahment Kingdom relevance and expansion
through love and the Gospel
 Chlooqure

35 % 65%
Cure ful Ca
1
LAT, 450 ]

2%
Cure beath
Overal Cure (g8-7. )
Overal deatt:((-39. )
Erpected Cost : t2557-5o
Cost Rer Cue i M 3,6o244

SP
I201

65°lo 32%
Cure Fail sp

Oveall Ce 99 36. CACT * 4501

2%
oSt per Cure /42 Cure Deatt